Novartis Suspends Investments, Other Business Activities in Russia
22 Marzo 2022 - 3:10AM
Noticias Dow Jones
By Cecilia Butini
Novartis AG said Tuesday that it has suspended capital
investments, media advertising and other promotional activities in
Russia as a result of sanctions imposed on the country due to its
war against Ukraine.
The Swiss pharma company also said it has paused the initiation
of new clinical trials and the enrollment of new participants in
existing trials, and added that these measures will be kept under
review.
Novartis said it remains committed to providing access to
medicines, and that it has donated antibiotics, painkillers and
other kinds of treatments to Ukraine and the border areas where
people are fleeing.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
March 22, 2022 04:55 ET (08:55 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Novartis (NYSE:NVS)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Novartis (NYSE:NVS)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
